Old Web
English
Sign In
Acemap
>
authorDetail
>
K. Wilcoxen
K. Wilcoxen
Medicine
Immunology
Antibody
therapeutic antibody
Cancer research
5
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
391: Highly selective, first-in-class furin inhibitor BOS-318 inhibits ENaC and restores airway hydration in cystic fibrosis
2021
Journal of Cystic Fibrosis
Lisa E.J. Douglas
James Reihill
M.W.-Y. Ho
J.M. Axten
N. Campobasso
K. Wilcoxen
S. L. Martin
Show All
Source
Cite
Save
Citations (0)
A preclinical evaluation of niraparib efficacy as monotherapy, maintenance and after olaparib treatment (PARP inhibitor after PARP inhibitor) in patient-derived ovarian xenograft tumor models
2017
European Journal of Cancer
K. Mikule
S Wang
S.J. Weroha
J. Nakashima
K. Wilcoxen
Show All
Source
Cite
Save
Citations (1)
Discovery of TSR-022, a novel, potent anti-human TIM-3 therapeutic antibody
2016
European Journal of Cancer
A Murtaza
Haley Laken
J. Da Silva Correia
P. McNeeley
Larry Altobell
Jian-Guo Zhang
P. Vancutsem
K. Wilcoxen
David Jenkins
Show All
Source
Cite
Save
Citations (19)
Design, synthesis, and SAR of pyrazolo pyridines as a potent corticotropin-releasing factor receptor antagonists
2001
Charles Q. Huang
M. Haddach
C. Chen
K. Wilcoxen
J. R. McCarthy
X Wang
D. Grigoriadis
E. B. D. S. uza
Show All
Source
Cite
Save
Citations (0)
1